查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
數位計量吸入器市場規模、佔有率和趨勢分析報告：按產品、適應症、類型、地區和細分市場預測，2023-2030 年
市場調查報告書
商品編碼
1321361

數位計量吸入器市場規模、佔有率和趨勢分析報告：按產品、適應症、類型、地區和細分市場預測，2023-2030 年

Digital Dose Inhaler Market Size, Share & Trends Analysis Report By Product (MDI, DPI), By Indication (Asthma, COPD), By Type (Branded Medication, Generic Medication), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 74 Pages | 商品交期: 2-10個工作天內

價格

數位計量吸入器市場成長和趨勢

根據Grand View Research, Inc.最新報告，預計到2030年，全球數位計量吸入器市場規模將達到533.2億美元，2023年至2030年年複合成長率為19.4%。

該市場利潤豐厚的成長的關鍵因素包括老年人口的不斷增加和慢性呼吸道疾病的激增。

中國、印度、巴西和菲律賓等新興國家的經濟發展帶來了人均收入的成長，預計這將影響對技術先進的呼吸設備的需求。此外，兒科和老年患者可以使用利用這些技術的呼吸設備來提高患者的依從性和劑量追踪，並增強患者與醫療保健提供者的聯繫，從而實現醫療資料的即時追踪。這些都是有影響力的渲染因素，並顯著推動未來九年的市場成長。

為了滿足目標人群未滿足的需求，供應商正在擴大生產單位，並確保長期成長和盈利，他們將目標瞄準慢性肺病和氣喘，例如亞太地區和未滿足的需求。的因此，上述業務擴張趨勢預計將在預測期內推動數位計量吸入器的使用。

此外，美國FDA 推動的固定劑量組合 (FDC) 的引入、學名藥的快速採用以及對數位健康平台的需求不斷成長等有利的政府舉措將影響這些數位吸入器的快速採用。人口成長率的一個重要決定因素，預計這種情況在未來幾年將持續下去。

世界人口迅速老齡化，睡眠呼吸中止呼吸暫停、氣喘和慢性阻塞性肺病等各種慢性呼吸道疾病的患病率不斷上升，對醫療保健系統產生了負面影響。這將進一步增加對創新呼吸設備的需求，並推動預測期內數位計量吸入器市場的成長。

數位計量吸入器市場報告亮點

  • 2015年，計量吸入器（MDI）領域的收入最大，為5.639億美元。
  • 然而，由於人們越來越認知到在計量吸入器中用作推進劑的氯氟烴的不利影響，乾粉吸入器 (DPI) 領域預計將成為成長最快的類別，在預測期內年複合成長率16.9%。此外，MDI 藥物刺激的盛行以及人們對使用 DPI 相對於 MDI 的益處的認知不斷增強，是預計在預測期內進一步促進 DPI 使用的關鍵因素。
  • 2015年，品牌製藥呼吸設備類別佔據最大市場佔有率，達7.476億美元。
  • 2015年北美地區所佔佔有率最大，超過38.64%。這一巨大佔有率歸因於該地區多家醫療器械廠商的存在，包括強生公司、Cohera Medical, Inc、Teleflex Medical, Inc 和 Covidien Plc。該地區有6000多家醫療器械生產企業，其中大多數是中小企業。此外，老年人口的成長以及氣喘和慢性阻塞性肺病等慢性呼吸道疾病患病率的激增是預計在預測期內積極加強數位計量吸入器市場的少數因素之一。
  • 亞太地區 (APAC) 預計在預測期內將以年複合成長率17.2% 的良好速度成長。醫療保健支出的快速增加以及美國FDA 在中國和印度等亞太國家的製造地的增加預計將對數位計量吸入器的市場滲透率產生重大影響。
  • 此外，人們對呼吸設備中採用的各種創新技術的認知不斷提高，政府持續採取有利措施進一步鼓勵使用學名藥，以及對醫療設備電子零件製造的各種補貼；以及多項稅收優惠政策，使醫療設備出口能夠順利進行。預計該地區在預測期內將大力促進市場成長。
  • 市場領先的公司包括 Glenmark Pharmaceuticals Ltd.、Novartis AG、Propeller Health、AstraZeneca Plc、Philips Respironics、Opko Health, Inc. 和 Teva Pharmaceuticals Industries Ltd.。

目錄

第1章 調查方法與範圍

  • 市場區隔和範圍
  • 調查方法
  • 資訊採購
  • 資訊或資料分析
  • 市場形成和檢驗
  • 型號詳情
  • 二手資訊清單
  • 主要資訊清單
  • 目的

第2章 執行摘要

第3章 數位計量吸入器市場變量、趨勢、範圍

  • 市場體系預測
    • 母公司市場預測
    • 相關/附市場預測
  • 採用和成長預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 數位計量吸入器市場分析工具
    • 行業分析-波特
    • PESTEL分析

第4章 數位定量吸入器：產品估算和趨勢分析

  • 數位計量吸入器市場：要點
  • 數位計量吸入器市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 定量吸入器 (MDI)
  • 乾粉吸入器 (DPI)

第5章 數位計量吸入器市場：類型估計和趨勢分析

  • 數位計量吸入器市場：要點
  • 數位計量吸入器市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 品牌藥品
  • 學名藥

第6章 數位計量吸入器市場：適應症估計和趨勢分析

  • 數位計量吸入器市場：要點
  • 數位計量吸入器市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 氣喘
  • 慢性阻塞性肺病（COPD）
  • 其他

第7章 數位計量吸入器市場：區域估計和趨勢分析

  • 區域展望
  • 按地區分類的數位計量吸入器市場：主要市場要點
  • 北美
    • 2018-2030 年市場估計和預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 鯛魚
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • 3M Company
    • AstraZeneca Plc
    • Glenmark Pharmaceuticals Ltd.
    • Novartis AG
    • Propeller Health
    • Sensirion AG Switzerland
    • Opko Health, Inc.
    • Teva Pharmaceuticals Industries Ltd
    • BEXIMCO Pharmaceuticals
    • GlaxoSmithKline Plc
    • Mundipharma Deutschland GmbH & Co. KG
Product Code: 978-1-68038-953-1

Digital Dose Inhaler Market Growth & Trends

The global digital dose inhaler market size is expected to reach USD 53.32 billion by 2030, registering a CAGR of 19.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The key factors contributing to the lucrative growth of this market include the continually increasing elderly population and the surging prevalence of chronic respiratory diseases.

As a result of impactful economic developments in the fast emerging countries, such as China, India, Brazil, Philippines, and others, there has been growth in the per capita income, which is thus expected to influence the demand for the technologically advanced respiratory devices. Moreover, these technology-enabled respiratory devices are greatly sought after among the pediatric and the geriatric population so as to improve the patient medication compliance, dose tracking, and to enhance patient-healthcare practitioner connectivity that would enable real-time tracking of healthcare data; these serve as high impact rendering factors, significantly driving the market growth in the next nine years.

In order to cater to the unmet needs of the target population, the vendors are expanding their production units and in addition, targeting the niche areas where the prevalence of chronic lung diseases and asthma are on the rise, such as Asia Pacific and MEA regions, to ensure long-term growth and profitability. Therefore, the aforementioned, business expansion trends are expected to boost the usage rates of the digital dose inhalers over the forecast period.

Additionally, favorable government initiatives, such as the introduction of Fixed Dose Combination (FDC), advanced by the U.S. FDA, fast increasing adoption of generic drugs, and the growing demand for digital health platforms are the identified crucial determinants influencing the rapid uptake of these digital inhalers, which is expected to continue in the coming years.

Rapidly increasing geriatric population worldwide in conjunction with the growing prevalence of various chronic respiratory conditions, such as chronic sleep apnea, asthma, COPD, among others negatively impact healthcare system. This would further escalate the demand for innovative respiratory devices thereby encouraging the digital dose inhalers market growth during the forecast period.

Digital Dose Inhaler Market Report Highlights

  • In 2015, the metered dose inhalers (MDIs) segment accounted for the maximum revenue of USD 563.9 million, mainly on account of the increased preference for MDIs.
  • However, the dry powder inhalers (DPIs) segment is expected to emerge as the fastest growing category with a CAGR of 16.9% over the forecast period owing to the growing awareness regarding the adverse effects of chlorofluorocarbons employed as a propellant in the MDIs. Moreover, widespread incidences of drug irritation due to MDI and rising awareness regarding the benefits of using DPIs over MDIs are the leading factors expected to further drive the usage rates of DPIs over the forecast period.
  • In 2015, the branded medication respiratory devices category accounted for the largest market share of USD 747.6 million attributable to the steadily growing need for advanced respiratory drugs and the awareness related to the benefits of combination medication gaining prominence.
  • North America held the maximum share of over 38.64% in 2015. This large share is attributed to the presence of several medical device players in this region, such as Johnson & Johnson, Cohera Medical, Inc., Teleflex Medical, Inc., Covidien Plc, and others. There are over 6,000 medical device companies domiciled in this region, which majorly consists of small and medium sized enterprises (SMEs). Moreover, the soaring geriatric population count and the surging prevalence of chronic respiratory diseases, such as asthma and COPD, are few factors, among others, expected to positively reinforce the digital dose inhaler market over the forecast period.
  • The Asia Pacific (APAC) region is anticipated to grow at a lucrative pace with a CAGR of 17.2% over the forecast period. The upsurge in the healthcare expenditure and the increasing number of U.S. FDA manufacturing sites in APAC countries, such as in China and India, are expected tosignificantly impact the market penetration of the digital dose inhalers.
  • Furthermore, the growing awareness regarding the various innovative technologies employed in the respiratory devices, the ongoing favorable government initiatives that further encourage the use of generic drugs, various subsidies for electronic component manufacturing of medical devices, and several tax benefits that enable medical device exports from this region are anticipated to strongly reinforce the market growth over the forecast period.
  • Some leading players of the market include Glenmark Pharmaceuticals Ltd., Novartis AG, Propeller Health, AstraZeneca Plc, Philips Respironics, Opko Health, Inc., and Teva Pharmaceuticals Industries Ltd.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Type
    • 1.1.3. Indication
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Indication outlook
    • 2.2.3. Type outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Digital Dose Inhaler Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Digital Dose Inhaler Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Digital Dose Inhaler: Product Estimates & Trend Analysis

  • 4.1. Digital Dose Inhaler Market: Key Takeaways
  • 4.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Metered Dose Inhaler (MDI)
    • 4.3.1. Metered Dose Inhaler (MDI) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Dry powder Inhaler (DPI)
    • 4.4.1. Dry Powder Inhaler (DPI) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Digital Dose Inhaler Market: Type Estimates & Trend Analysis

  • 5.1. Digital Dose Inhaler Market: Key Takeaways
  • 5.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Branded Medication
    • 5.3.1. Branded medication market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Generic Medication
    • 5.4.1. Generic medication market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Digital Dose Inhaler Market: Indication Estimates & Trend Analysis

  • 6.1. Digital Dose Inhaler Market: Key Takeaways
  • 6.2. Digital Dose Inhaler Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Asthma
    • 6.3.1. Asthma market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Chronic Obstructive Pulmonary Disease (COPD)
    • 6.4.1. Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Digital Dose Inhaler Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Digital Dose Inhaler Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. 3M Company
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. AstraZeneca Plc
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Glenmark Pharmaceuticals Ltd.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Novartis AG
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Propeller Health
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Sensirion AG Switzerland
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Opko Health, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Teva Pharmaceuticals Industries Ltd
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. BEXIMCO Pharmaceuticals
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. GlaxoSmithKline Plc
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Mundipharma Deutschland GmbH & Co. KG
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 5 North America digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 9 Canada digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 12 Europe digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Europe digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 19 UK digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 22 France digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 23 France digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 24 France digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 25 Italy digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 28 Spain digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 30 Spain digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 31 Sweden digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 33 Sweden digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Norway digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 36 Norway digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Denmark digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 44 China digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 45 China digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 46 China digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 47 Japan digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 50 India digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 51 India digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 52 India digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Thailand digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 55 Thailand digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 56 South Korea digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 58 South Korea digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 59 Latin America digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 61 Latin America digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Latin America digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 64 Brazil digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 65 Brazil digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 66 Mexico digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 67 Mexico digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 68 Mexico digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 69 Argentina digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 70 Argentina digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 71 Argentina digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa digital dose inhaler market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Africa digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 78 South Africa digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 79 UAE digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 80 UAE digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 81 UAE digital dose inhaler market, by indication, 2018 - 2030 (USD Million)
  • Table 82 Kuwait digital dose inhaler market, by product, 2018 - 2030 (USD Million)
  • Table 83 Kuwait digital dose inhaler market, by type, 2018 - 2030 (USD Million)
  • Table 84 Kuwait digital dose inhaler market, by indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Digital dose inhaler: Market outlook
  • Fig. 9 Digital dose inhaler competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Digital dose inhaler market driver impact
  • Fig. 15 Digital dose inhaler market restraint impact
  • Fig. 16 Digital dose inhaler market strategic initiatives analysis
  • Fig. 17 Digital dose inhaler market: Product movement analysis
  • Fig. 18 Digital dose inhaler market: Product outlook and key takeaways
  • Fig. 19 Metered Dose Inhaler (MDI) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Dry Powder Inhaler (DPI) market estimates and forecasts, (USD million), 2018 - 2030
  • Fig. 21 Digital dose inhaler market: Type movement analysis
  • Fig. 22 Digital dose inhaler market: Type outlook and key takeaways
  • Fig. 23 Branded medication market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Generic medication market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Digital dose inhaler market: Indication movement analysis
  • Fig. 26 Digital dose inhaler market: Indication outlook and key takeaways
  • Fig. 27 Asthma market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Chronic Obstructive Pulmonary Disease (COPD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global digital dose inhaler market: Regional movement analysis
  • Fig. 31 Global digital dose inhaler market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)